A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

NCT04583735 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen